Matthias Bossard
Overview
Explore the profile of Matthias Bossard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGrath B, Pinilla-Echeverri N, Wood D, Bainey K, Sheth T, Schampaert E, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(3):297-307.
PMID: 39641724
Background: In the COMPLETE (Complete vs Culprit-Only Revascularization to Treat Multi-Vessel Disease After Early PCI for STEMI) trial, complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel...
2.
Jolly S, dEntremont M, Lee S, Mian R, Tyrwhitt J, Kedev S, et al.
N Engl J Med
. 2024 Nov;
392(7):633-642.
PMID: 39555823
Background: Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. Methods: In this multicenter trial with a 2-by-2 factorial...
3.
Jolly S, dEntremont M, Pitt B, Lee S, Mian R, Tyrwhitt J, et al.
N Engl J Med
. 2024 Nov;
392(7):643-652.
PMID: 39555814
Background: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is...
4.
Wolfrum M, Moccetti F, Conrad N, Loretz L, Madanchi M, Bossard M, et al.
J Invasive Cardiol
. 2024 Jul;
36(11).
PMID: 39052516
No abstract available.
5.
Brunner S, Moccetti F, Loretz L, Conrad N, Bossard M, Attinger-Toller A, et al.
Cardiovasc Revasc Med
. 2024 Jul;
70:71-75.
PMID: 38987046
Background: In patients undergoing transcatheter aortic valve replacement (TAVR), elevated pre-procedural C-reactive protein (CRP) levels are frequently observed. Its impact on long-term results of TAVR is unclear. The aim of...
6.
Tersalvi G, Bossard M, Aeschbacher S, Wiencierz A, Beer J, Rodondi N, et al.
Int J Cardiol
. 2024 Jul;
412:132320.
PMID: 38964549
Background: Atrial fibrillation (AF) is common in patients with heart failure (HF). Real-world data about long-term outcomes and rhythm control interventions use in AF patients with and without HF remain...
7.
Rai V, Iglesias J, Bossard M, Dahal K, Chang C, Tomaniak M
Front Cardiovasc Med
. 2024 Jun;
11:1437555.
PMID: 38903963
No abstract available.
8.
Moccetti F, Wolfrum M, Bossard M, Attinger-Toller A, Loretz L, Cuculi F, et al.
Catheter Cardiovasc Interv
. 2024 May;
104(1):134-144.
PMID: 38736247
Background: In transcatheter aortic valve replacement (TAVR), transfemoral (TF) access offers several advantages over alternative access routes. Advances in sheaths and valve delivery technology have catalyzed the feasibility of TF-TAVR,...
9.
Zhi Y, Madanchi M, Cioffi G, Brunner J, Stutz L, Gnan E, et al.
Cardiovasc Interv Ther
. 2024 Apr;
39(3):262-272.
PMID: 38642291
Background: Patients with acute myocardial infarction (AMI) and large thrombus burden (LTB) still represent a challenge. Afflicted patients have a high morbidity and mortality. Aspiration thrombectomy is often ineffective in...
10.
Madanchi M, Bossard M, Majcen I, Cioffi G, Ferraro F, Gnan E, et al.
J Invasive Cardiol
. 2024 Mar;
36(3).
PMID: 38441987
Objectives: Despite the introduction of improved drug eluting stents (DES), the rate of repeat revascularization procedures following percutaneous coronary interventions (PCI) in coronary chronic total occlusions (CTO) remains high. By...